Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Loss of appetite is commonly observed in patients with dyspepsia in clinical practice. This study aimed to investigate the clinical characteristics and effectiveness of Korean medical treatment for patients with dyspepsia and appetite loss. Clinical records of 225 patients with dyspepsia who visited the Digestive Diseases Clinic of Kyung Hee University Korean Medicine Hospital between January 1, 2022, and July 31, 2024, were reviewed. Patients were classified into the anorexia with dyspepsia (AD) group (101) and non-anorexia with dyspepsia group (124), based on the presence of appetite loss. Clinical characteristics were analyzed accordingly. The AD group had a higher tendency to experience various gastrointestinal symptoms, including upper abdominal discomfort, early satiety, and upper abdominal bloating compared to the non-anorexia with dyspepsia group. Anorexia was positively linked to various aspects of quality of life, such as eating habits, energy levels, psychological, and role-functioning capacity. In electrogastrography analysis, the AD group exhibited a significantly higher preprandial dominant frequency. However, no significant differences were found in other electrogastrography parameters or heart rate variability results, indicating a limited impact of anorexia on physical function. Following 4 weeks of Korean medicine treatment, the AD group showed substantial improvements in overall quality of life. Dyspepsia accompanied by anorexia was more strongly linked to psychosocial and physical health challenges than dyspepsia with good appetite, highlighting Korean medical treatment as a potential therapeutic option for patients with anorexia.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12303461 | PMC |
| http://dx.doi.org/10.1097/MD.0000000000043454 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Oral drug treatments of erectile dysfunction: a AFU/SFMS systematic review.
Fr J Urol
September 2025
Department of urology, Maison de Santé Protestante de Bordeaux-Bagatelle, Talence, France; Department of urology, HIA Robert-Picqué, Villenave d'Ornon, France.
Objectives: To evaluate the efficacy and safety of oral phosphodiesterase-5 inhibitors (PDE5Is) in the treatment of erectile dysfunction (ED). Additionally, to compare various PDE5Is and assess their suitability for different patient populations.
Evidence Acquisition: A systematic review of literature published from January 1999 to January 2023 was conducted following the PICOS criteria.
Transcutaneous auricular vagal nerve stimulation improves functional dyspepsia with sleep disturbance via enhanced vagal activity: a randomized controlled trial.
Int J Surg
September 2025
Division of Gastroenterology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Background: Functional dyspepsia (FD) is often comorbid with sleep disturbance. Transcutaneous auricular vagal nerve stimulation (taVNS) is a new and non-invasive therapeutic option. This study aimed to investigate its effects and possible mechanisms on FD with sleep disturbance.
View Article and Find Full Text PDFExosomal hsa-miR-3649 and hsa-miR-202-3p in Gastric Juice as Potential Biomarkers for Functional Dyspepsia with a Previous Helicobacter pylori Infection.
Intern Med
September 2025
Department of Gastroenterology, Graduate School of Medicine, Osaka Metropolitan University, Japan.
Objective Specific microRNAs (miRNAs) in patients with functional dyspepsia (FD) and previous Helicobacter pylori (HP) infections have not been elucidated. This study aimed to investigate exosomal miRNAs as potential biomarkers of FD in patients with a previous HP infection using a liquid biopsy. Methods Six patients with FD and six age- and sex-matched healthy controls (HCs) with a previous HP infection were enrolled in the discovery cohort.
View Article and Find Full Text PDFAdherence to Clinical Practice Guidelines for Management of Epithelial Precancerous Conditions and Lesions in the Stomach in Europe.
Endoscopy
September 2025
Gastroenterology Department, Instituto Português de Oncologia do Porto, Porto, Portugal.
Background And Aims: The first international guideline for managing preneoplastic conditions of the stomach (MAPS I) was published in 2012, followed by an update (MAPS II) in 2019. As adherence to these guidelines remains uncertain, we evaluated adherence by comparing the management of preneoplastic gastric conditions before and after the introduction of MAPS I and II in selected European centers.
Methods: Patients data were retrieved from nine endoscopy units in seven European countries during three periods: pre-MAPS I (2010/2011), post-MAPS I (2017/2018), and post-MAPS II (2022/2023).
Poor sleep quality (PSQ) prevalence in patients with functional dyspepsia (FD): a systematic review and meta-analysis.
Ann Med Surg (Lond)
September 2025
Department of Medicine, Manhal University, Almanhal Academy for Science, Khartoum, Sudan.
Background: Functional dyspepsia (FD), a disease of the gastroduodenal tract, is one of the functional gastrointestinal disorders (FGID) characterized by postprandial fullness and epigastric pain not attributed to any underlying organic diseases. Sleep quality refers to individuals' satisfaction with their overall sleep, including sleep initiation, maintenance, duration, and feeling refreshed upon waking. Despite frequent associations between sleep disorders and FGID, comprehensive data on poor sleep quality (PSQ) in FD patients is lacking.
View Article and Find Full Text PDF